BPC-157
BPC-157 appears in the clinic's current menu. Inclusion records advertising and does not establish approval, formulation, safety, or recovery outcomes.
Provider source ↗
Unclaimed9 services cataloged
Scottsdale Peptides
Scottsdale, AZ · Telehealth available
Provider overview
About Scottsdale Peptides
Scottsdale Peptides publishes one Scottsdale address, public phone and email, and a booking pathway connected to Grace Orthopedics. Its current site identifies Dr. Slater in the clinical consultation process and advertises a catalog of more than 25 peptides, including named recovery, skin, metabolic, immune, and GLP-1-related offerings. The site says remote work may be possible depending on the concern, but it does not publish an exact state list, so only Arizona is recorded. Compound names, testing language, and program descriptions remain provider-reported; this listing does not validate the site's safety, testing, effectiveness, regulatory, formulation, pharmacy, or availability claims.
At a glance
- Market role
- Direct patient-care provider
- Care model
- Telehealth and In person
- Coverage
- 1 listed jurisdictions
- Pharmacy pathway
- Not publicly established
503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.
Service catalog
Programs and services
Provider-advertised services, grouped for quick scanning with all details visible.
01
2Provider-advertised recovery peptides
TB-500
The site names thymosin beta-4/TB-500 in its current catalog; current availability and regulatory status require direct confirmation.
Provider source ↗02
1Provider-advertised skin and recovery peptides
GHK-Cu and KPV
GHK-Cu and KPV are listed as separate offerings without directory-side adoption of the provider's skin, gut, or recovery claims.
Provider source ↗03
1Provider-advertised immune-health peptides
Thymosin alpha-1
Thymosin alpha-1 appears in the clinic's peptide menu; the listing does not claim immune or clinical outcomes.
Provider source ↗04
2Provider-advertised metabolic compounds
5-Amino-1MQ
5-Amino-1MQ is named by the provider. Its status, formulation, availability, and suitability are not independently established.
Provider source ↗AOD peptide program
The clinic expressly describes AOD peptides as experimental; this listing preserves that caution and makes no weight or metabolic claim.
Provider source ↗05
2Medical weight management
Semaglutide-related program
Semaglutide appears in the public catalog without a disclosed brand or formulation.
Provider source ↗Tirzepatide-related program
Tirzepatide appears in the public catalog without a disclosed brand or formulation.
Provider source ↗06
1Testing and ongoing care
Consultation, record review, and ongoing monitoring
The clinic describes a consultation using health history, laboratory work, imaging, and records followed by individualized planning and monitoring.
Provider source ↗Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.
Coverage and research
Explore this provider’s markets
Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.
Continue comparing
Related provider profiles
Evidence
Sources reviewed
Logo reproduced from the provider’s official website for identification. Logo source ↗
These links support the public facts recorded here. Provider-published information is not an independent endorsement.
- 1Scottsdale Peptides — Official Website ↗
Supports: identity location phone email and operations · Checked Jul 25, 2026
- 2Scottsdale Peptides — Treatments ↗
Supports: named peptide and metabolic catalog · Checked Jul 25, 2026
- 3Scottsdale Peptides — Frequently Asked Questions ↗
Supports: clinical consultation labs records and dr slater · Checked Jul 25, 2026
- 4Scottsdale Peptides — Remote Care FAQ ↗
Supports: limited remote care statement · Checked Jul 25, 2026